|
Catecholaminergic polymorphic ventricular tachycardia |
Chain29 |
Determine the risk of death caused by Catecholaminergic polymorphic ventricular tachycardia |
|
Wolff-Parkinson-White Syndrome |
Chain30 |
Determine the risk of death caused by Wolff-Parkinson-White Syndrome |
|
Hip arthritis |
Chain31 |
Determine risk of hip arthritis |
|
Knee arthritis |
Chain32 |
Determine risk of knee arthritis |
|
Wrist arthritis |
Chain33 |
Determine risk of wrist arthritis |
|
Hand arthritis |
Chain34 |
Determine risk of hand arthritis |
|
Malignant Hyperthermia |
Chain35 |
Determine risk of malignant hyperthermia |
|
Adrenocortical Carcinoma |
Chain36 |
Determine risk for cancer of the adrenal glands |
|
Increased risk of very life threatening reaction to nitrous oxide |
Chain37 |
Determine risks of nitrous oxide |
|
No increased risk but person is a carrier of potentially life threatening reaction to nitrous oxide (and may pass on to his or her children) |
Chain38 |
Determine risk of passing on risk of nitrous oxide as parent carriers |
|
Alpha-1-Antitrypsin Deficiency |
Chain39 |
Determine predisposition to severe lung disease |
|
Aspirin Effectiveness |
Chain40 |
Determine how effective asprin is |
|
Asthma |
Chain41 |
Determine predisposition to asthma |
|
Increased risk of asthma when exposed to second hand smoke as a child |
Chain42 |
Determine presdispositon for asthma when exposed to second hand smoke |
|
Atrial Fibrillation |
Chain43 |
Determine predisposition to abnormal heart beat |
|
Von Willebrand Disease, Type 1 |
Chain44 |
Determine predisposition to bleeding disorder |
|
Von Willebrand Disease, Type 2B |
Chain45 |
Determine predisposition to bleeding disorder |
|
Von Willebrand Disease, Type 2M |
Chain46 |
Determine predisposition to bleeding disorder |
|
Bleeding Risk due to Factor V Deficiency (Factor V Soul-2) |
Chain47 |
Determine predisposition for slow blood clotting |
|
Bleeding Risk due to Prothrombin Deficiency (Barcelona) |
Chain48 |
Determine risk of bleeding disorder |
|
Bleeding Risk due to Prothrombin Deficiency (Quick I) |
Chain49 |
Determine risk of bleeding disorder |
|
Bleeding Risk due to Severe Factor V Deficiency (R1133X) |
Chain50 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Antithrombin III Deficiency |
Chain51 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Factor V Hong Kong |
Chain52 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Factor V Leiden |
Chain53 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Factor V R2 |
Chain54 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Protein C Deficiency |
Chain55 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Protein S Deficiency |
Chain56 |
Determine risk of bleeding disorder |
|
Blood Clot Risk due to Prothrombin 20210 |
Chain57 |
Determine risk of bleeding disorder |
|
Brain Aneurysm |
Chain58 |
Determine predisposition for brain aneurysm |
|
Bronchiectasis |
Chain59 |
Determine predisposition for lung disorder |
|
Chronic Respiratory Disease |
Chain60 |
Determine predisposition for chronic respiratory disease |
|
Breast cancer |
Chain61 |
Determine predisposition for breast cancer |
|
Increased risk of breast cancer risk with exposure to radiation |
Chain62 |
Determine risk for breast cancer with exposure to radiation |
|
Colorectal Cancer |
Chain63 |
Determine predisposition for colon cancer |